Arterial revascularization in patients with diabetes: An overview

Journal for Vascular Ultrasound

Volumn 30, Issue 4, 2006, Pages 221-227

  Rollins, David L ^a   Kalakuntla, Vikram ^a   Wilson, Anne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ARTERIOGRAPHY; ARTERY BYPASS; ARTERY INTIMA PROLIFERATION; ARTERY RECONSTRUCTION; ATHERECTOMY; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC FOOT; DISEASE PREDISPOSITION; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; FOOT ULCER; HEALTH CARE COST; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LABORATORY TEST; LIMB SALVAGE; MINIMALLY INVASIVE SURGERY; OUTCOME ASSESSMENT; PATIENT MONITORING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RESTENOSIS; REVASCULARIZATION; REVIEW; RISK FACTOR; TREATMENT OUTCOME; WOUND CARE;

EID: 34047105121     PISSN: 15443167     EISSN: None     Source Type: Journal    
DOI: 10.1177/154431670603000407     Document Type: Review

References (16)

1. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion: National Diabetes Fact Sheet. Atlanta: CDC; 2003.
2. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion: United States Diabetes Statistics. Atlanta: CDD; 2003.
3. The Diabetes and Control and Complications Trials Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-983.
4. The Vascular Surgical Society of Great Britain and Ireland. critical limb ischemia: management and outcome: report of a national survey. Eur J Vasc Endovasc Surg. 1995;10:108-113.
5. DePalma RG. Patterns of peripheral atherosclerosis: implications for treatment. In: Shepard J, ed: Atherosclerosis: Developments, Complications, Treatment. New York: Elsevier; 1987:161.
6. Rosen AB, DePalma R, Victor Y. Risk factors in atherosclerosis. Arch Surg 1973;107:303.
7. The long-term mortality and its predictors in patients with critical leg ischemia. The I.C.I.A. Group, the Study Group of Critical Chronic Ischemia of the Lower Extremities. Eur J Vasc Endovasc Surg. 1997;114:91-95.
8. Regensteiner JG, Hiatt WR. Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med 2002;112:49-57.
9. Kallero KS, Bergqvist D, Cederholm C, et al. Late mortality and morbidity after arterial reconstruction: the influence of arteriosclerosis in popliteal artery trifurcation. J Vasc Surg 1985;2:541-546.
10. LoGerfo FW, Coffman JD. Vascular and microvascular disease in the diabetic foot: implications for foot care. N Engl J Med. 1984;311:1615-1619.
11. Neville RF. Diabetic revascularization: improving PTFE limb salvage in the absence of autogenous vein. Semin Vasc Surg. 2003; 16:19-26.
12. Hakaim AG, Gordon JK, Scott TE. Early outcome of in situ femoral tibial reconstruction among patients with diabetes alone versus diabetes and end stage renal failure: analysis of 83 limbs. J Vasc Surg. 1998;27:1054-1055.
13. Taylor LM, Porter JM. Results of lower extremity bypass in the diabetic patient. Semin Vasc Surg. 1992;5:226-233.
14. Mills JL. Infrainguinal Vein Graft Surveillance: How and When in Zierler R (ed): Semin Vasc Surg. 2001;14:169-176.
15. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstructions: description of a new technique and a preliminary report of its application. Circulation 1964;30:654.
16. Gruntzig A, Kumpe DA. Technique of percutaneous transluminal angioplasty with the Gruntzig balloon catheter. AJR Am J Roentgenol. 1979;132:547.